✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Tripeptide Research Compound
KPV is a tripeptide studied in laboratory settings for its role in inflammatory signaling pathways and immune-related cellular responses. Research often explores its interaction with cytokine regulation and tissue response mechanisms in controlled experimental models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
KPV is a synthetic tripeptide composed of lysine–proline–valine and represents a fragment derived from the alpha-melanocyte–stimulating hormone (α-MSH) sequence. It is developed for controlled laboratory research involving peptide-mediated signaling systems.
In scientific literature, KPV is studied in experimental models examining inflammatory signaling pathways, cytokine-associated regulatory frameworks, and epithelial interaction systems under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
KPV is the C-terminal tripeptide fragment of α-MSH and has been evaluated in research focused on immune-related signaling pathways and epithelial system interaction models. Experimental studies examine its interaction within inflammatory regulatory frameworks and peptide-mediated signaling systems in controlled laboratory environments.
Research publications have explored its pathway-level regulatory characteristics and signaling behavior under structured experimental conditions.
The parent peptide α-MSH was originally studied for its role in melanocortin signaling systems. Subsequent biochemical investigations identified smaller active fragments, including KPV, for further experimental evaluation.
Research expanded into models exploring peptide fragment interaction within inflammatory and epithelial signaling systems under laboratory conditions.
Laboratory investigations into KPV have focused on inflammatory signaling pathway models and epithelial system regulatory frameworks. Research environments evaluate peptide interaction within cytokine-associated signaling systems and cellular response mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 30mg of lyophilized KPV. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis.
PubMedDrug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
PubMedPepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
